Anti-sarcoglycan gamma antibodies are used for the immunodetection of the protein encoded by the SGCG gene. In humans, the canonical protein has a reported length of 291 amino acid residues and a mass of 32.4 kDa. Its subcellular localization is in the cell membrane and cytoplasm. It is reported to be expressed in skeletal and heart muscle. A member of the Sarcoglycan beta/delta/gamma/zeta protein family, it is a known component of the sarcoglycan complex, a subcomplex of the dystrophin-glycoprotein complex which forms a link between the F-actin cytoskeleton and the extracellular matrix. Post-translational modifications have been described, including glycosylation. Other names for this target antigen include 35DAG and A4. Gene orthologs have been identified in the mouse, rat, bovine, frog, zebrafish, chimpanzee and chicken species. A number of sarcoglycan gamma antibodies have been mentioned in research publications and have associated citations. Western Blot is a widely used application for these antibodies. ELISA and Immunohistochemistry are also common applications.